https://www.blogger.com/blogger.g?blogID=8926591330622788414#comments

Sunday 14 December 2014

Global Surgical Incision Closure Market - Industry Segment, Trends and Forecast, 2013 – 2019

Effective closure of surgical incisions plays a crucial role in post-surgical process to regain normal anatomical functions and maintain the integrity of tissues. Thus, the primary objective of surgical incision closure devices is to stop bleeding i.e. hemostasis and to close or seal the wound both externally and internally. Failure to close surgical incisions effectively can lead to severe medical complications such as infection and scarring. The commonly involved technique in conventional surgical incision closure is the use of surgical sutures for stitching together the incised skin edges. But modern methods introduced are more advanced and convenient; to mention some of the advanced methods - use of adhesives, hemostats, medical staples and sealants.
The commonly used surgical incision closure products include:
  • Surgical sutures
  • Absorbable
  • Non-absorbable
  • Hemostats
  • Collagen based
  • Oxidized regenerated cellulose based
  • Thrombin based
  • Ligating clips
  • Medical staples
  • Tissue sealants
  • External
  • Internal
Technologically advanced surgical incision closure devices, for instance, tissue sealants, hemostats and similar other devices play an important role in driving the market due to benefits offered such as fewer traumas, reduced risk of infections, better cosmetic outcomes and reduced recovery time. Also, there are many surgical incision closure products in the pipeline that are exploring usage of alternative materials, for example, titanium suture needles to replace medical grade stainless steel needles used for suturing among others; thus high investment in R&D is likely to lead the development and supply of newer, effective surgical incision closure products. This in turn is likely to drive the demand for surgical incision closure products in the future. However, the growth of such devices could be hindered in the future due to rise in preference for minimally invasive surgical procedures among patients.
North America followed by Europe are expected to be the largest markets owing to a high consumer base of aesthetic surgeries, knee replacement surgeries, hip replacement surgeries and spinal fusions. Asia-Pacific is estimated to register a remarkable growth because of few notable reasons such as improvements in healthcare infrastructure, increased access to healthcare services, establishment of new hospitals and diagnostic centers and rising spends in the healthcare segment.
Few of the leading companies involved in the development, manufacturing and distribution of surgical incision closure devices are 3M HealthCare, Axya Medical, Inc., Baxter International Inc., BTG International, Inc., Covidien Ltd., CryoLife, Inc., Ethicon Inc., Genzyme Biosurgery, Inc, Henkel Loctite Corporation/Henkel Group, Smith & Nephew PLC, Tyco Healthcare/Tyco International among others.
Browse Market Research Blogs:


Global Cardiac Assist Devices Industry Segment and Forecast, 2013 – 2019

Cardiac Assist Devices (CAD) are type of mechanical pumps that work along with the heart to improve its pumping efficiency and maintain the optimum blood flow throughout the body. Cardiac Assist Devices can be segmented in three types ventricular assist devices, intra-aortic balloon pumps (IABPs) and total artificial heart. Ventricular assist device (VAD) is a mechanical pump which takes blood from a lower chamber of the heart and pumps it to the body and vital organs. Ventricular devices are of two types right ventricular assist device (RVAD), left ventricular assist device (LVAD) and if both the ventricular assist devices are used they’re known as biventricular assist device (BIVAD). Intra-aortic balloon pump is a type of CAD device which increases myocardial oxygen perfusion and cardiac output at the same time. Total artificial heart is a device which replaces the lower chambers of heart and recovers failing heart by performing all functions of a normal heart.
Cardiac assist devices market is expected to be driven by global aging population and increase in cardiovascular diseases. A another factor responsible for market growth of this market is lack of donor hearts for transplantation leading to increase in cardiac assist devices implantations in patients with severe heart complications. In future technological advancements and more efficient and minimally invasive devices are expected to drive the market.
North America is the leading markets for Cardiac Assist Devices (CAD) because of highest heart failure cases diagnosed, technological development, high patient awareness and reimbursement coverage for CAD implantation procedures. Europe is the second largest market following North Amercia with second largest highest prevalence for cardiac diseases and increase in population exceeding 60 - 65 years of age group. Asia Pacific and Rest of the World are the regions including China, India, Brazil, Russia and South Africa has significantly large number of underserved patients suffering with cardiac diseases hence represented as future attractive markets for CAD.
Some of the key players of Cardiac Assist Devices (CAD) market are Berlin Herat GmbH, ABIOMED, Inc., MAQUET GmbH & Co. KG, Thoratec Corporation, Teleflex Incorporated, HeartWare International, Inc. and SynCardia Systems, Inc.
Browse Market Research Blogs: